Tokyo Olympics 2020: Pfizer, BioNTech to donate vaccines for athletes and officials, confirms IOC

·1 min read

Lausanne: Vaccine developers Pfizer and BioNTech will donate doses to inoculate athletes and officials preparing for the Tokyo Olympics, the IOC said Thursday.

Delivery of doses is set to begin this month to give Olympic delegations time to be fully vaccinated with a second shot before arriving in Tokyo for the games, which open on 23 July.

It's the second major vaccination deal for the International Olympic Committee (IOC). An agreement was announced in March between the IOC and Olympic officials in China to buy and distribute Chinese vaccines ahead of the Tokyo Games and next year's Beijing Winter Games.

The new Pfizer offer gives the IOC greater coverage worldwide ahead of Tokyo with most countries yet to authorise emergency use of Chinese vaccines.

"We are inviting the athletes and participating delegations of the upcoming Olympic and Paralympic Games to lead by example and accept the vaccine where and when possible," IOC president Thomas Bach said in a statement.

The Pfizer donation followed talks between the firm's chairman and CEO, Albert Bourla, and Japanese Prime Minister Yoshihide Suga.

"Following this conversation, the Japanese government had a meeting with the IOC and now the donation plan has been realised," Pfizer said in a statement.

The IOC said any vaccination program must be done "in accordance with each country's vaccination guidelines and consistent with local regulations."

The IOC-China vaccine deal includes two doses being made available to the general public for each dose received by an Olympic participant in that country.

Also See: Tokyo Olympics 2020: More tests for athletes, but questions about the Games remain

Tokyo Olympics 2020: Full venues at pandemic-hit Games 'very difficult', say organisers

Tokyo Olympics 2020: Athletes making political, social justice demonstrations to get global union’s backing

Read more on Sports by Firstpost.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting